Persistent increase in caffeine concentrations in people who stop smoking.
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
protein (gpl20) in the viral envelope.4During the first few weeks of treatment with zidovudine platelet counts rose in both patients with thrombocytopenia and those with normal counts.This suggests that reticuloendo- thelial inhibition may not be the only mechanism.The eventual fall in platelet count with longer treatment probably had several causes, but the only significant association in our patients was with the development of probable myelotoxicity due to zidovudine, suggesting that this was the cause.We found no easily identifiable variables before treatment, other than a low platelet count, that predicted a good eventual response.Current treatments for thrombocytopenia related to HIV infection have potential disadvantages-namely, immunosuppression from steroids and splenectomy with consequent risk of progression of the disease, problems of availability of high dose immuno- globulins, and lack of access to veins, especially in intravenous drug users.Zidovudine may be a useful alternative for symptomatic thrombocytopenia.The good response among those with even severe thrombo- cytopenia shows that this should not be considered a contraindication to treatment.We acknowledge Lothian Health Board, the American Foundation for AIDS Research for financial support (PJF), and our colleagues Drs J A Gray and P D Welsby for access to results in their patients.1 Hymes KB, Greene JB, Karpatkin S. The effect of azidothymidine on HIV related thrombocytopenia.N EnglJ Med 1988;318:516-7.2 Swiss Group for Clinical Studies on the Acquired Immunodeficiency Syndrome.Zidovudine for the treatment of thrombocytopenia associated with human immunodeficiency virus (HIV).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effect of smoking on caffeine clearance
Parsons, W. D., & Neims, A. H. (1978) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt197824140 · Cited by 302
Coffee consumption and the incidence of coronary heart disease.
LaCroix, A. Z., Mead, L. A., Liang, K.-Y., Thomas, C. B., & Pearson, T. A. (1986) · New England Journal of Medicine · doi:10.1056/nejm198610163151601 · Cited by 183
Cited by
Fredholm, B. B., Bättig, K., Holmén, J., Nehlig, A., & Zvartau, E. E. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01396-6 · Cited by 2,624
Clinical Pharmacology of Caffeine
Benowitz, N. L. (1990) · Annual Review of Medicine · doi:10.1146/annurev.me.41.020190.001425 · Cited by 420
Self-citationNicotine Medications for Smoking Cessation
Henningfield, J. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511023331807 · Cited by 352
Caffeine Use in Sports, Pharmacokinetics in Man, and Cellular Mechanisms of Action
Magkos, F., & Kavouras, S. A. (2005) · Critical Reviews in Food Science and Nutrition · doi:10.1080/1040-830491379245 · Cited by 344
Caffeine Intake is Associated with a Lower Risk of Cognitive Decline: A Cohort Study from Portugal
Santos, C., Lunet, N., Azevedo, A., de Mendonça, A., Ritchie, K., & Barros, H. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-091303 · Cited by 100
“On the other hand, it is also important to note that caffeine half-life is decreased in smokers, contributing to a weaker protective effect under the same dietary exposures [47].”
Metadata
- Authors
- Benowitz, N. L., Hall, S. M., & Modin, G.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 1989-04-22
- Volume
- 298
- Issue
- 6680
- Pages
- 1075-1076
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W2007346169
- Cited by
- 56
- References
- 2
- FWCI
- 1.98
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Persistent increase in caffeine concentrations in people who stop smoking. https://app.cochat.ai/papers/10.1136/bmj.298.6680.1075
- The paper
- Benowitz, N. L., Hall, S. M., & Modin, G. (1989). Persistent increase in caffeine concentrations in people who stop smoking. BMJ. https://doi.org/10.1136/bmj.298.6680.1075
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.